Position in FATE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$225,240
+$41,294 QoQ
Shares Held
187,700
0.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,019,315 | $1,499,784,339 | |
| 2 | ARGX |
Argenx SE
|
395,661 | $367,082,405 | |
| 3 | GMAB |
Genmab A/S
|
8,644,877 | $237,474,771 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
292,338 | $182,284,436 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,002,026 | $141,443,136 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,696,538 | $132,788,029 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
981,521 | $112,551,013 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,453,504 | $108,256,977 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $225,240 | 187,700 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $183,946 | 187,700 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $236,502 | 187,700 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $210,224 | 187,700 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $115,798 | 146,580 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $241,857 | 146,580 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $513,030 | 146,580 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $480,782 | 146,580 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $736,789 | 100,380 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $601,242 | 160,760 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $342,507 | 161,560 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $605,138 | 127,130 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $580,260 | 101,800 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,045,162 | 301,800 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $2,281,338 | 101,800 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,513,556 | 141,790 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,503,285 | 141,947 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,284,430 | 141,590 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,392,039 | 141,590 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $12,340,670 | 142,190 | Shares | Defined | 2021-07-30 | |
| 2021-03-31 | $10,650,066 | 129,170 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $9,020,256 | 99,200 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $3,653,258 | 91,400 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,943,798 | 85,800 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,792,347 | 80,700 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||